Our Board of Directors

Bioscience Affinity Co-Chair
Magda Marquet, Ph.D.
Founder and Co-Chair, Althea Technologies

Dr. Marquet is founder and Co-Chair of Althea Technologies, Inc., a leading provider of contract services to the biotech and pharmaceutical industry. She is also the founder and co-Chair of AltheaDX, a molecular diagnostics company focused on oncology. Dr. Marquet has a passion for entrepreneurship and has been involved in the start up and seed financing of over ten life sciences companies including Traversa Therapeutics, Biomatrica, Huya Biosciences, Coda Genomics, Trius Therapeutics, and Regenemed.

Dr. Marquet has over twenty years of experience in the biotechnology industry in the United States and Europe. She was formerly co-President and co-Chief Executive Officer of Althea Technologies and Executive Director of Pharmaceutical Development at Vical Incorporated, where she patented several novel methods for the production of clinical grade DNA for use in gene therapy and DNA vaccines. Prior to joining Vical, Dr. Marquet held management positions at Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene.

Dr. Marquet is a member of the Board of Directors of BIOCOM and Athena San Diego. She is also the Honorary Consul of the Principality of Andorra in the United States. Dr. Marquet holds a Ph.D in Biochemical Engineering from the University of Toulouse/INSA, France. Dr. Marquet has received numerous awards throughout her career. She was voted “most admired CEO” by the San Diego Business Journal in 2007. She was the winner of the 2005 Ernst&Young Entrepreneur of the Year award in the Life Sciences category, the 2005 UCSD Athena Pinnacle award in Technology and the 2004 Women Who Mean Business award from the San Diego Business Journal. Althea Technologies has won numerous awards recognizing its fast growth and company culture, being voted “Best Company to Work For” several years in a row. Dr Marquet has been recently featured in Entrepreneur Magazine (“The Boys Club”).